Here's how the Johnson and Johnson stock could move after its opioid case ruling

Les Funtleyder, E-Squared Capital Management, and CNBC's Meg Tirrell join "The Exchange" to discuss the potential domino effect that could take place following the ruling of the Johnson and Johnson opioid case.